CD4 and tuberculosis: In the absence of suitable diagnostics, trials have been designed to evaluate a strategy whereby HIV-infected patients in high TB prevalence settings with very low CD4 counts but no overt TB diagnosis are randomised to receive or not receive empiric TB treatment, with mortality being the primary outcome of interest [42].